Latest Breaking News On - Belvedere trading - Page 3 : comparemela.com

SuRo Capital Corp (NASDAQ:SSSS) Short Interest Down 45 6% in April

SuRo Capital Corp. (NASDAQ:SSSS – Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 26,800 shares, a drop of 45.6% from the March 31st total of 49,300 shares. Currently, 0.1% of the company’s shares are short sold. […]

New yorkUnited statesSan franciscoJanney montgomery scottByrne asset managementCalton associates incBelvedere tradingSuro capital company profileBarrington researchSuro capital corpSuro capitalGet free reportAsset managementMontgomery scottSuro capital daily

Barnes & Noble Education (NYSE:BNED) Coverage Initiated by Analysts at StockNews com

Barnes & Noble Education (NYSE:BNED) Coverage Initiated by Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesCraig hallumBelvedere tradingBarnes noble education company profileNeedham companyBarnes noble education incNoble educationFree reportGet free reportNoble education daily

ProQR Therapeutics (NASDAQ:PRQR) Price Target Increased to $2 00 by Analysts at Citigroup

ProQR Therapeutics (NASDAQ:PRQR) Price Target Increased to $2 00 by Analysts at Citigroup
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sigma securitiesVirtu financialTower research capitalProqr therapeutics company profileBelvedere tradingFree reportModerate buyGet free reportResearch capitalFinancial markets

Citigroup Raises ProQR Therapeutics (NASDAQ:PRQR) Price Target to $2 00

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) had its target price lifted by analysts at Citigroup from $1.80 to $2.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s price objective suggests a potential upside of 2.56% from the company’s […]

Tower research capitalBelvedere tradingSigma securitiesProqr therapeutics company profileVirtu financialGet free reportResearch capitalFinancial markets

Independence Contract Drilling (NYSE:ICD) Upgraded to Hold at StockNews com

Independence Contract Drilling (NYSE:ICD – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Independence Contract Drilling Trading Down 1.0 % Shares of Independence Contract Drilling stock opened at $1.91 on Thursday. The firm has […]

United statesNorthern trust corpIndependence contract drilling incAcadian asset managementBelvedere tradingGoldman sachs group incIndependence contract drillingGet free reportContract drilling trading downContract drillingAsset managementSachs groupTrust corpPermian basinIndependence contract drilling daily